139 related articles for article (PubMed ID: 6126001)
21. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
22. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Martin IC
Acta Psychiatr Scand; 1975 Feb; 51(2):110-8. PubMed ID: 235189
[TBL] [Abstract][Full Text] [Related]
23. Off-label second generation antipsychotics for impulse regulation disorders: a review.
Scheltema Beduin A; de Haan L
Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
[TBL] [Abstract][Full Text] [Related]
24. Plasma level monitoring of antipsychotic drugs. Clinical utility.
Dahl SG
Clin Pharmacokinet; 1986; 11(1):36-61. PubMed ID: 2868820
[TBL] [Abstract][Full Text] [Related]
25. Neuroleptic treatment of HIV-associated psychosis. HNRC group.
Sewell DD; Jeste DV; McAdams LA; Bailey A; Harris MJ; Atkinson JH; Chandler JL; McCutchan JA; Grant I
Neuropsychopharmacology; 1994 Jul; 10(4):223-9. PubMed ID: 7945732
[TBL] [Abstract][Full Text] [Related]
26. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
O'Brien CP; DiGiacomo JN; Webb W
Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044
[TBL] [Abstract][Full Text] [Related]
27. [COGENTINE (BTMS) IN THE TREATMENT OF NEUROLEPTIC SYNDROMES].
VOLMAT R; BEAUDOUIN JL; COLLIN J; NICOLAS-CHARLES PJ; ALLERS G
Encephale; 1964; 53():SUPPL:250-61. PubMed ID: 14161539
[No Abstract] [Full Text] [Related]
28. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
Termińska K; Mrowiec W
Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
[TBL] [Abstract][Full Text] [Related]
29. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Sukhodolsky DG; Scahill L; Gadow KD; Arnold LE; Aman MG; McDougle CJ; McCracken JT; Tierney E; Williams White S; Lecavalier L; Vitiello B
J Abnorm Child Psychol; 2008 Jan; 36(1):117-28. PubMed ID: 17674186
[TBL] [Abstract][Full Text] [Related]
30. Neuroleptic prescribing to the community elderly in Nottingham.
Thacker S; Jones R
Int J Geriatr Psychiatry; 1997 Aug; 12(8):833-7. PubMed ID: 9283928
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
[No Abstract] [Full Text] [Related]
32. The strategy and value of neuroleptic drug monitoring.
Curry SH
J Clin Psychopharmacol; 1985 Oct; 5(5):263-71. PubMed ID: 2864358
[TBL] [Abstract][Full Text] [Related]
33. [Effect of neuroleptic therapy on the structure of an episode in acute alcoholic psychoses].
Kolotilin GF; Mostovoĭ SM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(6):894-7. PubMed ID: 2888249
[TBL] [Abstract][Full Text] [Related]
34. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
Balon R; Berchou R; Zethelius M
Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
[TBL] [Abstract][Full Text] [Related]
35. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
[TBL] [Abstract][Full Text] [Related]
36. The inadvisability of neuroleptic medication in Wilson's disease.
Tu J
Biol Psychiatry; 1981 Oct; 16(10):963-8. PubMed ID: 6118185
[TBL] [Abstract][Full Text] [Related]
37. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Correll CU; Leucht S; Kane JM
Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963
[TBL] [Abstract][Full Text] [Related]
38. Basic principles of rapid neuroleptization.
Mason AS; Granacher RP
Dis Nerv Syst; 1976 Oct; 37(10):547-51. PubMed ID: 9267
[No Abstract] [Full Text] [Related]
39. Maintenance antipsychotic drugs do prevent relapse: a reply to Tobias and MacDonald.
Davis JM; Gosenfeld L; Tsai CC
Psychol Bull; 1976 May; 83(3):431-47. PubMed ID: 6986
[No Abstract] [Full Text] [Related]
40. Psychiatric drug treatment in children.
Heath A
J Maine Med Assoc; 1979 May; 70(5):181-9. PubMed ID: 36437
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
